Aimei Gao

Dr. Aimei Gao


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
ZKZun-Ping Ke
Zun-Ping Ke
PXPeng Xu
Peng Xu
YSYan Shi
Yan Shi
AGAimei Gao
Aimei Gao
MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN

30 May 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
AGAimei Gao
Aimei Gao
XZXiao-Yu Zhang
Xiao-Yu Zhang
ZKZun-Ping Ke
Zun-Ping Ke
Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway

21 February 2023 in Medicina
Verified
Journal Article
Open access
PDF file
ZKZun-Ping Ke
Zun-Ping Ke
YWYuling Wang
Yuling Wang
GSGuzailinur Silimu
Guzailinur Silimu
ZWZhangsheng Wang
Zhangsheng Wang
AGAimei Gao
Aimei Gao
Background and Objectives: This study aims to illustrate the mechanisms underlying the therapeutic effect of Icariin after myocardial infarction (MI). Materials and Methods: Based on the network pharmacology strategy, we predict the therapeutic targets of Icariin against MI and investigate the pharmacological molecular mechanisms. A topological network was created. Biological process and Kyoto Encyclopedia of Genes and Genomes pathway enrichment were also performed. We also conducted the molecular docking analysis to stimulate the component–target interaction further and validate the direct bind effect. Results: Network pharmacology analysis identified 61 candidate genes related to the therapeutic effect of Icariin against MI. EGFR, AKT1, TP53, JUN, ESR1, PTGS2, TNF, RELA, HSP90AA1, and BCL2L1 were identified as hub genes. The biological processes of the candidate targets were significantly involved in the reactive oxygen species metabolic process, response to hypoxia, response to decreased oxygen levels, response to oxidative stress, regulation of reactive oxygen species metabolic process, and so forth. Overall, biological process enrichment analysis indicated that the protective effect of Icariin against MI might be associated with oxidative stress. Moreover, the pathway analysis showed that the candidate targets were closely associated with lipid and atherosclerosis, AGE-RAGE signaling pathway in diabetic complications, HIF-1 signaling pathway, etc. We identified the conformation with the lowest affinity score as the docking conformation. The simulated molecular docking was displayed to illustrate the topical details of the binding sites between Icariin and TNF protein. Conclusions: This study provides an overview of the mechanisms underlying the protective effect of Icariin against MI.